A Case of Recurrent Urinary Tract Infection Successfully Treated during Homeopathic Supportive Care in Oncology

Abstract

Introduction A 32-year-old patient with colon cancer consulted for homeopathic supportive care (HSC). She had also suffered from recurrent urinary tract infections (RUTIs) for 20 years. Could homeopathy treat these two very different issues with the same medicine?

The Patient's Main Concerns Though the main reason for the consultation was a fear of the side effects of chemotherapy, the presence of Escherichia coli-induced RUTIs affected the patient's quality of life.

Interventions and Outcomes The repertory listing highlighted Pulsatilla as the patient's homeopathic constitutional medicine. It was prescribed both for HSC and also for RUTI. In association with Arsenicum album and Nerves, Pulsatilla enabled a good tolerance to chemotherapy, with rapid recovery from peripheral neuropathies. In combination with Colibacillinum, Pulsatilla provided relapse-free curing of the RUTIs. The MOdified NARanjo Criteria for Homeopathy (MONARCH) Inventory score was +9.

Conclusion The one individual's two different clinical complaints were treated with a constitutional homeopathic medicine, Pulsatilla, which covered the whole case. However, in HSC, the use of the constitutional remedy alone is rarely sufficient: it was reinforced by individualised symptomatic medication, organotherapy and isotherapy. For RUTI, isopathic and tubercular miasmatic treatments were each helpful. For both complaints, individualised homeopathy gave rapid, long-lasting and effective results.

Keywords

clinical case - constitutional remedy - homeopathic supportive care - Pulsatilla - recurrent urinary tract infection

Publication History

Received: 14 May 2022

Accepted: 08 September 2022

Article published online:
01 February 2023

• References

• 1 Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13: 269-284
• 2 Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003; 49: 53-70
• 3 Stahl G, Bagot JL. Homeopathic approach to the management of recurrent urinary tract infections. J Urol Ren Dis 2022; 7: 1262
• 4 Nwabudike LC. Classical homeopathy and bacterial urinary tract infections. Proc Rom Acad Ser A 2017; 19: 93-96
• 5 Gaertner K, von Ammon K, Frei-Erb M. Individualized homeopathic treatment in women with recurrent cystitis: a retrospective case series. Complement Med Res 2020; 27: 193-199
• 6 Bagot JL, Legrand A, Theunissen I. Use of homeopathy in integrative oncology in Strasbourg, France: multi-center cross-sectional descriptive study of patients undergoing cancer treatment. Homeopathy 2021; 110: 168-173
• 7 Bagot JL, Karp JC, Messerschmitt C. et al. Therapeutic recommendations of the International Homeopathic Society of Supportive Care in Oncology (IHSSC0). Rev d'Homéopathie 2017; 8: e47-e55
• 8 Frass M, Friehs H, Thallinger C. et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – A pragmatic randomized controlled trial. Complement Ther Med 2015; 23: 309-317
• 9 Frass M, Lechleitner P, Gründling C. et al. Homeopathic treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study. Oncologist 2021; 26: e523
• 10 Teut M, van Haselen RA, Rutten L, Lamba CD, Bleul G, Ulbrich-Zürni S. Case reporting in homeopathy – an overview of guidelines and scientific tools. Homeopathy 2022; 111: 2-9
• 11 Gagnier JJ, Kienle G, Altman DG. et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2014; 67: 46-51
• 12 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
• 13 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the Modified Naranjo Criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109: 191-197
• 14 Bagot JL. Pain in oncology, reality and paradox of homeopathic care. OBM Integrative and Complementary Medicine 2018; 3: 19
• 15 Massonnat N. Répertoire électronique PC Kent, version 2.2.M. St Just La Pendue: Evidence; 2020
• 16 Cazin JC, Cazin M, Gaborit JL. et al. A study of the effect of decimal and centesimal dilutions of arsenic on the retention and mobilization of arsenic in the rat. Hum Toxicol 1987; 6: 315-320
• 17 Aleixo DL, Benvenutti MJ, Lopes Lera KRJ, Ciupa L, Ferraz FN, Marques de Araújo S. The association of ponderal benznidazole with its ultra-high diluted formula reduces the toxic effects and allows increasing of dose in dose-dependent protocol in mice infected with Trypanosoma cruzi . Int J High Dilution Res 2015; 14: 10-19
• 18 Jäger T, Scherr C, Simon M, Heusser P, Baumgartner S. Effects of homeopathic arsenicum album, nosode, and gibberellic acid preparations on the growth rate of arsenic-impaired duckweed (Lemna gibba L.). ScientificWorldJournal 2010; 10: 2112-2129
• 19 Bagot JL. Using hetero-isotherapics in cancer supportive care: the fruit of fifteen years of experience. Homeopathy 2016; 105: 119-125
• 20 Bagot JL. Homeopathy and hetero-isotherapy, an interesting response to the side effects of targeted therapies in oncology. Rev d'Homéopathie 2017; 8: e35-e41
• 21 Sonntag D. Examination of immunological effects of homeopathic Escherichia coli extract (E. coli extractum 4x-8x) on bladder epithelial cells. J Complement Med Altern Healthcare 2017; 1: 1-2
• 22 Stahl G, Bagot JL. What should be the place of the tuberculinic chronic reactive mode in 21st century homeopathic practice?. Rev d'Homéopathie 2021; 12: e21-e29
• 23 Kent JT. Repertory of the Homeopathic Materia Medica, 4th ed. Chicago: Ehrhart & Karl; 1935
• 24 Hahnemann CFS. Organon of Medicine. 6th ed.. New Delhi, India: B. Jain Publishers Ltd.; 1991. paragraph 153